Tempus AI (NASDAQ:TEM) EVP Erik Phelps Sells 3,664 Shares

Tempus AI, Inc. (NASDAQ:TEM) EVP Erik Phelps sold 3,664 shares of Tempus AI stock in a transaction dated Tuesday, August 19th. The shares were sold at an average price of $74.65, for a total value of $273,517.60. Following the completion of the transaction, the executive vice president directly owned 94,115 shares in the company, valued at $7,025,684.75. This represents a 3.75% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink.

Erik Phelps also recently made the following trade(s):

• On Monday, June 16th, Erik Phelps sold 51,317 shares of Tempus AI stock. The shares were sold at an average price of $72.56, for a total value of $3,723,561.52.

Tempus AI Stock Performance

NASDAQ TEM opened at $76.71 on Friday. The firm has a market capitalization of $13.33 billion, a P/E ratio of -64.46 and a beta of 4.98. Tempus AI, Inc. has a 1-year low of $31.36 and a 1-year high of $91.45. The company has a debt-to-equity ratio of 2.58, a current ratio of 1.54 and a quick ratio of 1.43. The business’s 50-day simple moving average is $63.59 and its 200-day simple moving average is $59.09.

Tempus AI (NASDAQ:TEM) last released its quarterly earnings data on Friday, August 8th. The company reported ($0.22) earnings per share for the quarter, beating the consensus estimate of ($0.23) by $0.01. The business had revenue of $314.64 million for the quarter, compared to analyst estimates of $296.84 million. Tempus AI had a negative return on equity of 122.86% and a negative net margin of 20.98%.The company’s revenue was up 89.5% compared to the same quarter last year. During the same period in the previous year, the company posted ($6.86) EPS. Tempus AI has set its FY 2025 guidance at EPS. Equities analysts predict that Tempus AI, Inc. will post -6.15 EPS for the current year.

Institutional Investors Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently bought and sold shares of TEM. Vanguard Group Inc. increased its holdings in Tempus AI by 6,247.5% during the 1st quarter. Vanguard Group Inc. now owns 5,995,117 shares of the company’s stock worth $289,204,000 after purchasing an additional 5,900,668 shares during the last quarter. ARK Investment Management LLC increased its holdings in Tempus AI by 35.9% during the 1st quarter. ARK Investment Management LLC now owns 7,501,399 shares of the company’s stock worth $361,867,000 after purchasing an additional 1,981,755 shares during the last quarter. Nikko Asset Management Americas Inc. increased its holdings in Tempus AI by 31.5% during the 1st quarter. Nikko Asset Management Americas Inc. now owns 4,260,553 shares of the company’s stock worth $205,401,000 after purchasing an additional 1,021,460 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. increased its holdings in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company’s stock worth $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Finally, AQR Capital Management LLC purchased a new stake in Tempus AI during the 2nd quarter worth approximately $54,020,000. 24.22% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

TEM has been the topic of several analyst reports. Bank of America raised their target price on Tempus AI from $68.00 to $70.00 and gave the company a “neutral” rating in a report on Wednesday, June 25th. Guggenheim raised their target price on Tempus AI from $65.00 to $75.00 and gave the company a “buy” rating in a report on Monday, June 30th. Morgan Stanley raised their target price on Tempus AI from $65.00 to $68.00 and gave the company an “overweight” rating in a report on Tuesday, August 12th. Piper Sandler reiterated a “neutral” rating on shares of Tempus AI in a report on Friday, August 8th. Finally, BTIG Research raised their target price on Tempus AI from $75.00 to $85.00 and gave the company a “buy” rating in a report on Wednesday. Six research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $67.64.

About Tempus AI

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.